Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ADHD, affiliate, Alzheimer, andZemprelli, antitrust, Arnold, authorized, bound, chronic, circulated, ComfortisTM, Computation, Consummation, corrected, correction, Covance, cumulative, data, digit, diligence, disagree, disease, division, dollar, draft, duly, earlier, eighteen, Elanco, enjoining, error, Event, exceed, EXHIBIT, extend, extended, FASTTM, Fixed, flea, flexible, GAD, Genpharm, GmbH, Greenfield, group, guided, Hanish, heavy, Idaho, Ingenix, inhibitor, integrate, kinase, lapsed, London, manic, mentioned, merger, methodology, mid, milestone, Minnesota, moderate, NDA, negligible, Neolab, noncurrent, Notwithstanding, organization, Paulinia, Paulo, Pharmascience, platform, point, possession, preclinical, prelaunch, premature, proprietary, protein, Quantifying, Ratio, receipt, reclassification, Region, relationship, relocate, reserve, restated, restatement, restitution, rounding, SAB, Sao, SGX, shortterm, sNDA, sought, STADA, STADApharm, Statprobe, strength, stronger, sum, thereunto, toxicology, TPG, transdermally, transformation, TransPharma, unable, undersigned, understated, ViaDerm, violative, waived, widespread, withdrawn, Zemprelli
Filing tables
Filing exhibits
Related press release
LLY similar filings
Filing view
External links